Royalty Pharma Plc (RPRX) Institutional Ownership and Insiders Activity

Royalty Pharma Plc (RPRX) is widely held by institutional investors, with 4 tracked firms reporting positions valued at approximately $178.86M based on SEC Form 13F filings for the quarter ended March 31, 2026.

Dorsey Asset Management is the largest disclosed holder, reporting approximately $109.21M in RPRX holdings in its latest filing.

Institutional ownership among tracked investors remains highly concentrated, with Dorsey Asset Management representing the majority of disclosed value.